Top Gainers Technical Data -- Research on Northwest Biotherapeutics, Midstates Petroleum, AVEO Pharma, and Infinity Pharma - 100.7 Jack FM San Diego Radio & DSC- sandiegojack

Top Gainers Technical Data -- Research on Northwest Biotherapeutics, Midstates Petroleum, AVEO Pharma, and Infinity Pharma

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Investor-Edge

Editor Note: For more information about this release, please scroll to bottom.

LONDON, May 12, 2014 /PRNewswire/ --

The US markets saw a positive sentiment on Friday, May 09, 2014, with the NASDAQ Composite closing at 4,071.87, up 0.50%, the Dow Jones Industrial Average ending the session at 16,583.34, up 0.20% and the S&P 500 edging 0.15% higher to finish the trading session at 1,878.48. The session saw a positive impact from Consumer Discretionary, Health Care and Consumer Staples sectors along with a drag from Financials, Energy and Utilities sectors. A number of stocks saw large movements, including Northwest Biotherapeutics Inc. (NASDAQ: NWBO), Midstates Petroleum Company Inc. (NYSE: MPO), AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) and Infinity Pharmaceuticals Inc. (NASDAQ: INFI). Free technical research on NWBO, MPO, AVEO and INFI can be downloaded upon signing up at:

http://www.investor-edge.com/2387-register

Northwest Biotherapeutics Inc.'s stock finished Monday's session 5.26% higher at $5.20. A total of 0.59 million shares were traded, which was below its three months average volume of 1.17 million shares. The stock moved between $4.87 and $5.30 during the session. Over the past one month, Northwest Biotherapeutics Inc.'s shares have declined 18.75%. However, over the last three months and from the year's start, the company's stock has advanced 0.58% and 37.93%, respectively. The S&P 500 Health Care Sector Index mapped a gain of 0.58% during the session, and it has charted up 3.66% in the last one month. The company's shares are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $6.70 is greater than its 200-day moving average of $4.73. Northwest Biotherapeutics Inc.'s stock has a Relative Strength Index (RSI) of 34.74. Sign up today to read free research on NWBO at:

http://www.investor-edge.com/2387-NWBO-12May2014.pdf

On Friday, Midstates Petroleum Co Inc.'s stock fluctuated between $4.96 and $5.43 before ending the session 7.11% higher at $5.42. Midstates Petroleum Co Inc.'s stock reported a trading volume of 0.58 million shares, below its three months average volume of 0.72 million shares. Midstates Petroleum Co Inc.'s shares have surged 12.92% in the last one month and 22.35% in the previous three months. However, from the beginning of 2014, the company's stock has lost 18.13%. The S&P 500 Energy Sector Index registered a loss of 0.18% during the session, and it has charted up 5.63% in the last one month. The stock is trading above its 50-day and 200-day moving averages of $5.21 and $5.40, respectively. Moreover, shares of the company have an RSI of 51.53. Sign up today to read free research on MPO at:

http://www.investor-edge.com/2387-MPO-12May2014.pdf

AVEO Pharmaceuticals Inc.'s stock surged 7.27% on Friday, closing the day at an intra-day high of $1.18. The stock recorded a trading volume of 0.52 million shares, below its three months average volume of 0.58 million shares. The stock oscillated between $1.06 and $1.18 during the trading session. Over the previous three trading sessions and last one month, AVEO Pharmaceuticals Inc.'s shares have fallen by 1.67% and 18.62%, respectively. Also, the stock has lost 35.52% since the start of this year. The S&P 500 Health Care Sector Index reported a gain of 0.58% during the trading session and it has charted up 0.28% in the past three trading sessions. The stock is trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $1.89 is above its 50-day moving average of $1.52. Additionally, the stock has an RSI of 35.96. Sign up today to read free research on AVEO at:

http://www.investor-edge.com/2387-AVEO-12May2014.pdf

On Friday, shares in Infinity Pharmaceuticals Inc. recorded a trading volume of 0.45 million shares, lower than its three months average volume of 0.65 million shares. The stock ended the day at an intra-day high of $9.21, which was 7.09% above its previous day's closing of $8.60. Infinity Pharmaceuticals Inc.'s shares have gained 1.77% in the past three trading sessions. However, the stock has gone down by 8.72% in the last one month and 33.31% since the start of this year. The S&P 500 Health Care Sector Index mapped a gain of 0.58% during the session, and the index has charted up 0.43% in the previous three months. The company's stock is trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $14.66 is above its 50-day moving average of $11.62. Furthermore, shares of the company have an RSI of 39.21. Sign up today to read free research on INFI at:

http://www.investor-edge.com/2387-INFI-12May2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Midwest Television, Inc. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.